Horizon Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Horizon Investments's EW Position: Q1 2026 in Review
Horizon Investments increased its Edwards Lifesciences (EW) stake by 40% in Q1 2026, buying an estimated $723K and bringing the position to 30,717 shares worth $2.46M. The position accounts for 0.03% of the portfolio, ranked #430.
Horizon Investments first reported a position in EW in Q1 2019 and has held it in 18 quarters since. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Horizon Investments held 30,717 shares of Edwards Lifesciences worth $2.46M as of Q1 2026.
- Horizon Investments bought 8,774 Edwards Lifesciences shares in Q1 2026, an estimated $723K.
- Edwards Lifesciences made up 0.03% of Horizon Investments's portfolio in Q1 2026, its #430 holding.
- Horizon Investments first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 18 quarters since.
- 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.